Hua Medicine (Shanghai) Ltd. (HKG:2552)

Hua Medicine (Shanghai) Statistics

Total Valuation

HKG:2552 has a market cap or net worth of HKD 3.78 billion. The enterprise value is 2.88 billion.

Market Cap	3.78B
Enterprise Value	2.88B

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2552 has 983.66 million shares outstanding. The number of shares has increased by 0.44% in one year.

Current Share Class	983.66M
Shares Outstanding	983.66M
Shares Change (YoY)	+0.44%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	5.16%
Owned by Institutions (%)	3.93%
Float	652.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.87
PB Ratio	-26.20
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.83
EV / Sales	10.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.44

Financial Position

The company has a current ratio of 4.05

Current Ratio	4.05
Quick Ratio	3.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.71
Interest Coverage	-41.85

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-13.85%
Return on Invested Capital (ROIC)	-103.87%
Return on Capital Employed (ROCE)	-30.10%
Revenue Per Employee	1.62M
Profits Per Employee	-1.58M
Employee Count	168
Asset Turnover	0.16
Inventory Turnover	1.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +151.66% in the last 52 weeks. The beta is 1.18, so HKG:2552's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	+151.66%
50-Day Moving Average	2.81
200-Day Moving Average	2.00
Relative Strength Index (RSI)	70.54
Average Volume (20 Days)	11,457,546

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2552 had revenue of HKD 272.31 million and -266.20 million in losses. Loss per share was -0.27.

Revenue	272.31M
Gross Profit	132.73M
Operating Income	-383.43M
Pretax Income	-266.20M
Net Income	-266.20M
EBITDA	-368.19M
EBIT	-383.43M
Loss Per Share	-0.27

Balance Sheet

The company has 1.21 billion in cash and 319.44 million in debt, giving a net cash position of 893.45 million or 0.91 per share.

Cash & Cash Equivalents	1.21B
Total Debt	319.44M
Net Cash	893.45M
Net Cash Per Share	0.91
Equity (Book Value)	-144.16M
Book Value Per Share	-0.15
Working Capital	1.07B

Cash Flow

In the last 12 months, operating cash flow was -444.79 million and capital expenditures -3.01 million, giving a free cash flow of -447.80 million.

Operating Cash Flow	-444.79M
Capital Expenditures	-3.01M
Free Cash Flow	-447.80M
FCF Per Share	-0.46

Margins

Gross margin is 48.74%, with operating and profit margins of -140.80% and -97.75%.

Gross Margin	48.74%
Operating Margin	-140.80%
Pretax Margin	-97.75%
Profit Margin	-97.75%
EBITDA Margin	-135.21%
EBIT Margin	-140.80%
FCF Margin	n/a

Dividends & Yields

HKG:2552 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.44%
Shareholder Yield	n/a
Earnings Yield	-7.05%
FCF Yield	-11.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2552 has an Altman Z-Score of -5.15 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.15
Piotroski F-Score	1